Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Mitral Valve DiseaseMitral Valve StenosisMitral Valve Failure
Interventions
DEVICE

Foldax TRIA Mitral Valve

Mitral Valve Replacement

Trial Locations (3)

45219

The Christ Hospital, Cincinnati

46260

St. Vincent Hospital, Carmel

67226

Ascension Via Christi St. Francis, Wichita

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Foldax, Inc

INDUSTRY